Goodwin advised SV Health, Jeito and Samsara BioCapital on the deal.SV Health, Jeito and Samsara BioCapital led a $65 million Series A Financing of EyeBio. EyeBio is…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
